Dow Up 0.48% Nasdaq Up 0.43%

Celgene Corporation (CELG)

-NasdaqGS
91.36 0.05(0.05%) Aug 19, 4:00PM EDT
Prev Close:91.31
Open:92.00
Bid:91.25 x 100
Ask:92.00 x 200
1y Target Est:100.03
Beta:1.11
Next Earnings Date:23-Oct-14CELG Earnings announcement
Day's Range:91.30 - 92.28
52wk Range:66.29 - 92.28
Volume:4,053,911
Avg Vol (3m):4,612,860
Market Cap:73.04B
P/E (ttm):29.08
EPS (ttm):3.14
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CELG

Comparison

Symbol% ChgMkt Cap
CELGUp 0.05%73.04B
JNJ290.38B

Key Statistics

Forward P/E (1 yr):18.68
P/S (ttm):10.38
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :3.67
Quarterly EPS Est (Sep-14) :0.95
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.94

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback